Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1995; Volume 47,Issue 5
  • You have access
    Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.
    A Gomez-Muñoz, P A Duffy, A Martin, L O'Brien, H S Byun, R Bittman and D N Brindley
    Molecular Pharmacology May 1995, 47 (5) 833-839;
  • You have access
    Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide.
    A Copani, V Bruno, G Battaglia, G Leanza, R Pellitteri, A Russo, S Stanzani and F Nicoletti
    Molecular Pharmacology May 1995, 47 (5) 890-897;
  • You have access
    Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    S Lelièvre, Y Benchokroun and A K Larsen
    Molecular Pharmacology May 1995, 47 (5) 898-906;
  • You have access
    Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.
    D R Beidler and Y C Cheng
    Molecular Pharmacology May 1995, 47 (5) 907-914;
  • You have access
    Regulation of rat 5-hydroxytryptamine type 2 receptor gene activity: identification of cis elements that mediate basal and 5-hydroxytryptamine-dependent gene activation.
    Y L Du, B D Wilcox and J J Jeffrey
    Molecular Pharmacology May 1995, 47 (5) 915-922;
  • You have access
    Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism.
    N C Schaad, J Vanecek, I R Rodriguez, D C Klein, L Holtzclaw and J T Russell
    Molecular Pharmacology May 1995, 47 (5) 923-933;
  • You have access
    Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
    S Chen, R Knox, A D Lewis, F Friedlos, P Workman, P S Deng, M Fung, D Ebenstein, K Wu and T M Tsai
    Molecular Pharmacology May 1995, 47 (5) 934-939;
  • You have access
    Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.
    J Q Chen, A Ström, J A Gustafsson and E T Morgan
    Molecular Pharmacology May 1995, 47 (5) 940-947;
  • You have access
    GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
    C V Catapano, J S Dayton, B S Mitchell and D J Fernandes
    Molecular Pharmacology May 1995, 47 (5) 948-955;
  • You have access
    Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
    R A Vaughan
    Molecular Pharmacology May 1995, 47 (5) 956-964;
  • You have access
    Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
    R Bai, G F Taylor, J M Schmidt, M D Williams, J A Kepler, G R Pettit and E Hamel
    Molecular Pharmacology May 1995, 47 (5) 965-976;
  • You have access
    Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells.
    T A Esbenshade, A Hirasawa, G Tsujimoto, T Tanaka, J Yano, K P Minneman and T J Murphy
    Molecular Pharmacology May 1995, 47 (5) 977-985;
  • You have access
    Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.
    H M Beere, C M Chresta, A Alejo-Herberg, A Skladanowski, C Dive, A K Larsen and J A Hickman
    Molecular Pharmacology May 1995, 47 (5) 986-996;
  • You have access
    Gi is involved in ethanol inhibition of L-type calcium channels in undifferentiated but not differentiated PC-12 cells.
    D Mullikin-Kilpatrick, N D Mehta, J D Hildebrandt and S N Treistman
    Molecular Pharmacology May 1995, 47 (5) 997-1005;
  • You have access
    Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes.
    H Kankaanranta and E Moilanen
    Molecular Pharmacology May 1995, 47 (5) 1006-1013;
  • You have access
    Blockade of capacitive Ca2+ influx by Cl- channel blockers inhibits secretion from rat mucosal-type mast cells.
    M Reinsprecht, M H Rohn, R J Spadinger, I Pecht, H Schindler and C Romanin
    Molecular Pharmacology May 1995, 47 (5) 1014-1020;
  • You have access
    Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor.
    Y Nakagawa, K Nakajima, S Tayama and P Moldéus
    Molecular Pharmacology May 1995, 47 (5) 1021-1027;
  • You have access
    Free radical adducts in the bile of rats treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells.
    K T Knecht, Y Adachi, B U Bradford, Y Iimuro, M Kadiiska, Q H Xuang and R G Thurman
    Molecular Pharmacology May 1995, 47 (5) 1028-1034;
  • You have access
    kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
    G H Ma, R J Miller, A Kuznetsov and L H Philipson
    Molecular Pharmacology May 1995, 47 (5) 1035-1040;
  • You have access
    Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    E T Piros, P L Prather, H H Loh, P Y Law, C J Evans and T G Hales
    Molecular Pharmacology May 1995, 47 (5) 1041-1049;
  • You have access
    [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    C Labbé-Jullié, J M Botto, M V Mas, J Chabry, J Mazella, J P Vincent, D Gully, J P Maffrand and P Kitabgi
    Molecular Pharmacology May 1995, 47 (5) 1050-1056;
  • You have access
    Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro.
    A Ambrosini, L Bresciani, S Fracchia, N Brunello and G Racagni
    Molecular Pharmacology May 1995, 47 (5) 1057-1064;
  • You have access
    Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
    R M Brodbeck, B S Sachais and J E Krause
    Molecular Pharmacology May 1995, 47 (5) 1065-1071;
  • You have access
    Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    L Y Yang, L Li, M J Keating and W Plunkett
    Molecular Pharmacology May 1995, 47 (5) 1072-1079;
  • You have access
    Tissue-specific pharmacology of testosterone and 5 alpha-dihydrotestosterone analogues: characterization of a novel canine liver androgen-binding protein.
    A E Summerfield, P J Diaz Cruz, M P Dolenga, H E Smith, C D Strader and J H Toney
    Molecular Pharmacology May 1995, 47 (5) 1080-1088;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 5
1 May 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics